A Sensitive and Robust HPLC Assay with Fluorescence Detection for the Quantification of Pomalidomide in Human Plasma for Pharmacokinetic Analyses

Pomalidomide is a second generation IMiD (immunomodulatory agent) that has recently been granted approval by the Food and Drug Administration for treatment of relapsed multiple myeloma after prior treatment with two antimyeloma agents, including lenalidomide and bortezomib. A simple and robust HPLC...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Shahbazi, Shandiz, Peer, Cody J., Polizzotto, Mark N., Uldrick, Thomas S., Roth, Jeffrey, Wyvill, Kathleen M., Aleman, Karen, Zeldis, Jerome B., Yarchoan, Robert, Figg, William D.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3943695/
https://ncbi.nlm.nih.gov/pubmed/24486861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpba.2014.01.001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky